BDBM376096 N-(3-((5-amino-1,3,4- oxadiazol-2-yl)methyl)-1-(4- fluorophenyl)-1H-pyrazol-5- yl)-3-(1-methyl-1H-pyrazol-3- yl)-4- (trifluoromethyl)benzamide::US9914736, Compound 92

SMILES Cn1ccc(n1)-c1cc(ccc1C(F)(F)F)C(=O)Nc1cc(Cc2nnc(N)o2)nn1-c1ccc(F)cc1

InChI Key InChIKey=HKSVJVUZCZYCIB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 376096   

TargetHigh affinity nerve growth factor receptor(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM376096(US9914736, Compound 92 | N-(3-((5-amino-1,3,4- oxa...)
Affinity DataIC50: 1.30nMAssay Description: In this assay, U2OS cells express the human TrkA receptor as a fusion with the weakly complementing fragment of B-galactosidase, which DiscoverX cal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2020
Entry Details
Go to US Patent